메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Argon Medical Streamlines Distribution of Product and Enhan…

PLANO, Texas, July 15, 2025 -- Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announces the grand opening of its new Distribution & Education Center (ADEC), strategically located in Derby, United Kingdom. This state-of-the-art facility represents a major step forward in the company's global operations, serving as a dedicated hub for over 80 countries across Europe, Africa, the Middle East (EMEA), and Asia-Pacific (APAC) regions. Spanning more than 20,0
- 김갑성 기자
- 2025-07-15 17:12
Youthful Narrative Bridges Traditional Chinese Medicine to Gl…

LIAOCHENG, China, July 15, 2025 -- Amidst global challenges in chronic disease prevention and health management, Traditional Chinese Medicine (TCM)'s core principles of "preventive treatment of disease" (zhi wei bing, 治未病) and "harmony between humanity and nature" (tian ren he yi, 天人合一) are gaining international attention. The TCM cultural program The Young TCM Masters, co-produced by Dong-E-E-Jiao Co., Ltd, Shandong Radio and TV station, and Tencent Video, has achieved 5 billion online impressions through its innovative youth-oriented narrative. The program dismant
- 김갑성 기자
- 2025-07-15 16:45
AXA and China Biotech Services Sign Memorandum of Unders…

[ 메디채널 김갑성 기자 ] Joint effort to explore innovative cancer treatment solutions and broaden options for customers HONG KONG, July 15, 2025 -- AXA China Region Insurance Company (Bermuda) Limited, together with AXA International Reinsurance (Shanghai) Company Limited ("AXA"), is pleased to announce the signing of a strategic Memorandum of Understanding (MoU) with China Biotech Services Holdings Limited ("China Biotech Services"). The collaboration aims to explore innovative cancer treatment technologies, including Boron Neutron Capture Therapy ("BNCT") and
- 김갑성 기자
- 2025-07-15 15:23
Baraya Extended Care Closes Series B Funding Round Bring…

TVM Capital Healthcare's oversubscribed fundraise for Baraya Extended Care addresses critical gaps in long-term care, supporting Saudi Arabia's Vision 2030 healthcare goals. DUBAI, UAE and RIYADH, Saudi Arabia, July 15, 2025 -- TVM Capital Healthcare announces the closing of a Series B fundraising, surpassing its target and bringing the total capital raised to USD 124 million for Baraya Extended Care ["Baraya"], a leading provider of long-term care and rehabilitation services in Saudi Arabia. This fundraise comes at a critical moment, as Saudi Arabia faces a
- 김갑성 기자
- 2025-07-15 14:00
Baraya Extended Care Closes Series B Funding Round Bring…

TVM Capital Healthcare's oversubscribed fundraise for Baraya Extended Care addresses critical gaps in long-term care, supporting Saudi Arabia's Vision 2030 healthcare goals. DUBAI, UAE and RIYADH, Saudi Arabia, July 15, 2025 -- TVM Capital Healthcare announces the closing of a Series B fundraising, surpassing its target and bringing the total capital raised to USD 124 million for Baraya Extended Care ["Baraya"], a leading provider of long-term care and rehabilitation services in Saudi Arabia. This fundraise comes at a critical moment, as Saudi Arabia faces a
- 김갑성 기자
- 2025-07-15 14:00
2025 YF Life Jr. Astronauts Set to Embark on U.S. Space Exploratio…

HONG KONG and MACAU, July 15, 2025 -- The eight exceptional young explorers of the 2025 YF Life Jr. Space Camp Program are ready for their unforgettable nine-day space exploration journey in United States! These Jr. astronauts were selected after a series of intense competition by an esteemed panel of seven influential figures from various fields, including Ms. Candy Chea Shuk-mui, Ten Outstanding Young Persons Awardee and Media Veteran; Prof. Chan Chi Hou, Vice-President (Community Engagement) at City University of Hong Kong; Ir. Dr. Raymond Ho Chung-tai, Hong Kong Deputy to the 10th and 11
- 김갑성 기자
- 2025-07-15 10:30
Divamics' AI and Molecular Dynamics Platform Powers Breakthro…

SUZHOU, China, July 15, 2025 -- Divamics, a pioneer in AI-driven drug discovery, highlighted its critical role in advancing metabolic disease therapeutics through its advanced AI and molecular dynamics(MD) platform. This powerful platform recently supported the successful design of BGM1812, a novel dual AMY3R/CTR receptor agonist for obesity treatment, as published in the July 2025 issue of the Journal of Medicinal Chemistry. This achievement underscores Divamics' consistent ability to empower its partners in accelerating their drug discovery pipelines. AI-Powered Efficiency & Pre
- 김갑성 기자
- 2025-07-15 07:31
Ascletis Completes Dosing of All Participants in Its U.S. Clinical…

- The combination study, conducted in the U.S., is designed to evaluate the safety, tolerability and preliminary efficacy at Day 29 of a single-dose of ultra-long-acting subcutaneously administered ASC47 (half-life up to 40 days) in combination with four doses of semaglutide (0.5 mg, once weekly) in 28 participants with obesity. - Initiated in May 2025, all 28 participants were enrolled in less than two months. - Topline data are expected in the fourth quarter of 2025. HONG KONG, July 15, 2025 -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis&
- 김갑성 기자
- 2025-07-15 07:00
StandingTall: Revolutionise Falls Prevention Nationwide with…

SYDNEY, July 15, 2025 -- Miroma Project Factory (MPF), a leader in digital innovation for health and wellbeing, is proud to announce the expanded commercial release of StandingTall, the revolutionary home-based balance training program developed in collaboration with Professor Kim Delbaere, showcasing her life's work in falls prevention. StandingTall is a clinically validated, easy-to-use, and engaging exercise app designed to improve balance, boost confidence, and prevent falls among older adults. Now positioned for widespread adoption, StandingTall offers a proven, scalable s
- 김갑성 기자
- 2025-07-15 06:40
Concord Healthcare Announces Completion of China's Firs…

BEIJING, July 15, 2025 -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the stock code 2453.HK, announced that on July 11, 2025, Guangzhou Concord Cancer Center, a subsidiary of Concord Healthcare, successfully completed the first proton therapy treatment in China for a patient with choroidal malignant melanoma. Choroidal malignant melanoma is a common
- 김갑성 기자
- 2025-07-15 04:05

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2025-08-21_THU

2025-08-20_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 08월 21일 10시 40분